Skip to content

Evaluation of Deposits on Contact Lenses Worn Daily Wear

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00725153
Enrollment
55
Registered
2008-07-30
Start date
2008-03-31
Completion date
2008-09-30
Last updated
2012-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Keywords

Contact lens deposits, Soft contact lenses, Myopia

Brief summary

The purpose of this study was to measure front surface deposits on contact lenses when worn for ten hours.

Interventions

DEVICEBalafilcon A contact lenses (PureVision)

Commercially marketed, soft contact lenses worn bilaterally for 10 hours

DEVICEEtafilcon A contact lenses (Acuvue2)

Commercially marketed, soft contact lenses worn bilaterally for 10 hours

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older. * Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses. * Successfully wearing hydrogel or silicone hydrogel contact lenses prior to enrollment in the study. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Evidence or history of keratitis (dendritic keratitis); viral disease of the cornea and/or conjunctiva; acute bacterial disease of the cornea and/or conjunctiva and/or eyelids; infection of the eye; and/or fungal disease of the eye. * One functional eye or a monofit lens. * Ocular conditions such as active acute blepharitis, conjunctival infections, and iritis. * Any slit-lamp finding score of (1) at the Screening Visit as defined in protocol. * Use of concomitant topical ocular prescription or over-the-counter (OTC) ocular medications. * History of seasonal allergies with significant ocular side effects which may have an adverse impact on contact lens wear. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Front Surface Lens Deposits10 hoursFilm and discrete deposits were assessed with a slit-lamp after 10 hours of lens wear. Film deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=slight, deposition occupying 1-5% of lens front surface; 2=mild, deposition occupying 6-15% of lens front surface; 3=moderate, deposition occupying 16-25% of lens front surface; 4=severe, deposition occupying \>25% of lens front surface. Discrete deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=microdeposits (less than or equal to 10 dots); 2=microdeposits (greater than 10 dots); 3=macro deposits; 4=one or more jelly bumps. Participants were classified into Front Surface Lens Deposits \<2 (less than grade 2 for both film and discrete) and into front surface lens deposits \>1 (greater than grade 1 for either film, discrete, or both).

Countries

United States

Participant flow

Recruitment details

55 Subjects currently wearing hydrogel or silicone hydrogel lenses were recruited at 3 US and 1 United Kingdom study sites.

Pre-assignment details

Subjects randomized by lens order to wear PureVision and Acuvue 2 lenses for 10 hours each.

Participants by arm

ArmCount
Overall
All enrolled participants
55
Total55

Baseline characteristics

CharacteristicOverall
Age Continuous31.95 years
STANDARD_DEVIATION 12.03
Sex: Female, Male
Female
42 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 550 / 55
serious
Total, serious adverse events
0 / 550 / 55

Outcome results

Primary

Front Surface Lens Deposits

Film and discrete deposits were assessed with a slit-lamp after 10 hours of lens wear. Film deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=slight, deposition occupying 1-5% of lens front surface; 2=mild, deposition occupying 6-15% of lens front surface; 3=moderate, deposition occupying 16-25% of lens front surface; 4=severe, deposition occupying \>25% of lens front surface. Discrete deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=microdeposits (less than or equal to 10 dots); 2=microdeposits (greater than 10 dots); 3=macro deposits; 4=one or more jelly bumps. Participants were classified into Front Surface Lens Deposits \<2 (less than grade 2 for both film and discrete) and into front surface lens deposits \>1 (greater than grade 1 for either film, discrete, or both).

Time frame: 10 hours

Population: All enrolled participants.

ArmMeasureGroupValue (NUMBER)
PureVision Contact LensesFront Surface Lens DepositsDeposits Graded <227 Participants
PureVision Contact LensesFront Surface Lens DepositsDeposits Graded >128 Participants
Acuvue 2 Contact LensesFront Surface Lens DepositsDeposits Graded <232 Participants
Acuvue 2 Contact LensesFront Surface Lens DepositsDeposits Graded >123 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026